학술논문
Second-line and third-line therapy with nanoliposomal irinotecan (nal-IRI) in pancreatic cancer: a single-center experience and review of literature
Document Type
Article
Author
Source
In: Journal of Gastrointestinal Oncology . (Journal of Gastrointestinal Oncology, February 2023, 14(1):352-365)
Subject
Language
English
ISSN
2219679X
20786891
20786891